Poison Pill
How a Poison Pill Works
The mechanics are straightforward but powerful. The board of directors adopts a rights plan that distributes one “right” for every outstanding share. These rights remain dormant and effectively invisible until a trigger event occurs — typically when a single entity acquires (or announces a tender offer for) a threshold percentage of the company’s stock, usually 10–20%.
Once triggered, the rights activate and allow every shareholder except the acquirer to buy new shares at a deep discount (often 50% below market price). The flood of new cheap shares dilutes the acquirer’s ownership percentage dramatically, making the takeover economically unviable.
Types of Poison Pills
| Type | Mechanism | When It Activates |
|---|---|---|
| Flip-In | Shareholders (except the acquirer) buy the target’s shares at a discount | Acquirer crosses ownership threshold (e.g., 15%) |
| Flip-Over | Shareholders buy the acquirer’s shares at a discount after a merger | After the hostile merger is completed |
| Dead-Hand | Only the original board members who adopted the plan can redeem it | Same as flip-in, but resists board replacement via proxy fight |
| No-Hand (Delayed Redemption) | No one can redeem the pill for a set period (e.g., 6 months) after a board change | Same trigger, with a redemption lockout window |
The flip-in pill is by far the most common. Dead-hand and no-hand variants have faced legal challenges in several states and are viewed less favorably by courts because they entrench the board by preventing even newly elected directors from removing the defense.
Why Boards Adopt Poison Pills
The core argument is bargaining power. A poison pill doesn’t permanently block a takeover — it forces the acquirer to negotiate with the board rather than going directly to shareholders with a tender offer. This gives the board time to explore alternatives, solicit competing bids (potentially from a white knight), or negotiate a higher price.
Critically, the board can always choose to redeem the pill (typically for a nominal price like $0.01 per right) if a deal is ultimately in shareholders’ best interest. The pill is a negotiation tool, not a permanent blockade.
Poison Pill Triggers and Thresholds
The ownership threshold that triggers a poison pill has declined over time. In the 1980s and 1990s, 20% was standard. Today, many plans set the trigger at 10% or even lower — sometimes as low as 5% for plans specifically designed to protect net operating losses (NOL pills), where a change in ownership above 5% under IRC Section 382 could wipe out valuable tax assets.
Legal Landscape
The seminal case is Moran v. Household International (1985), where the Delaware Supreme Court upheld the poison pill as a valid exercise of the board’s business judgment. Courts generally allow pills as long as the board has a reasonable basis for believing a threat exists and the response is proportionate.
However, a board that uses a pill purely to entrench itself — blocking a clearly beneficial deal for shareholders — can face fiduciary duty challenges. Under Unocal and Revlon standards in Delaware, once a sale is inevitable, the board’s obligation shifts to maximizing shareholder value.
Criticism of Poison Pills
Shareholder activists and governance advocates frequently oppose poison pills, arguing they entrench management, reduce accountability, and suppress takeover premiums that shareholders would otherwise receive. Institutional investors and proxy advisory firms (ISS, Glass Lewis) generally recommend voting against pill ratification unless the board provides a compelling justification.
The counterargument is that pills have empirically been associated with higher takeover premiums — acquirers end up paying more when they can’t bypass the board, which benefits shareholders in deals that do proceed.
Poison Pill vs. Other Takeover Defenses
A poison pill is one tool in a broader defensive toolkit. A golden parachute compensates executives after a deal but doesn’t prevent it. A white knight is a friendly acquirer the board solicits as an alternative. A proxy fight is the acquirer’s offensive counter-move to replace the board and remove the pill. These strategies often interact — a hostile bidder may launch a proxy fight specifically to install directors who will redeem the poison pill.
Key Takeaways
- A poison pill lets existing shareholders buy discounted shares to massively dilute a hostile acquirer’s stake.
- The flip-in pill is the most common type; dead-hand variants face legal scrutiny.
- Pills don’t permanently block deals — the board can redeem the pill to allow a negotiated acquisition.
- Sudden adoption of a pill often signals early-stage M&A activity or activist pressure.
- Courts uphold pills under the business judgment rule, but boards must act in good faith and not purely for entrenchment.
Frequently Asked Questions
Can a poison pill be removed?
Yes. The board can redeem the pill at any time (usually for a nominal price). If shareholders disagree with the board’s refusal to redeem, they can wage a proxy fight to elect new directors who will remove it — unless it’s a dead-hand pill, which restricts redemption to the original adopting directors.
Do shareholders vote on poison pills?
Typically, no. Most poison pills are adopted unilaterally by the board without a shareholder vote. However, institutional investors increasingly pressure boards to submit pills for ratification, and some companies have adopted sunset provisions requiring periodic shareholder approval.
What is an NOL poison pill?
An NOL (net operating loss) pill sets the trigger threshold at 4.99% to prevent an ownership change under IRC Section 382 that would limit the company’s ability to use accumulated tax losses. These pills protect a specific financial asset rather than defending against a takeover.
Has a poison pill ever actually been triggered?
Triggered pills are extremely rare. The pill’s power is almost entirely deterrent — acquirers negotiate with the board or launch a proxy fight rather than cross the threshold and face catastrophic dilution. The threat is what gives the board leverage.